Print

Osiris Therapeutics, Inc. (OSIR) Names Lode Debrabandere Chief Operating Officer  
10/23/2012 9:16:55 AM

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) announced today it has promoted Lode Debrabandere, Ph.D. to the role of Chief Operating Officer (COO) reporting directly to Chief Executive Officer, C. Randal Mills, Ph.D. Dr. Debrabandere has been with Osiris since 2006 in various leadership positions, most recently serving as Senior Vice President for Therapeutics. During his time at Osiris, Dr. Debrabandere has played a key role in the development and approval of Osiris’ products including Prochymal® (remestemcel-L), which earlier this year became the world’s first stem cell drug to be granted marketing approval by an internationally recognized regulatory authority.
//-->